Related content

Comparative analysis of GATA3 mutation profiles between Asian and Western patients with breast cancer: Is there really a difference?

By Chandiramani Natasha   Kenny Paraic A.  

Cancer, Vol. 120, Iss. 17, 2014-09 ,pp. : 2778-2779

Blackwell Publishing

Access to resources Recommend Favorite

GATA3 mutations define a unique subtype of luminal-like breast cancer with improved survival

By Jiang Yi-Zhou   Yu Ke-Da   Zuo Wen-Jia   Peng Wen-Ting   Shao Zhi-Ming  

Cancer, Vol. 120, Iss. 9, 2014-05 ,pp. : 1329-1337

Blackwell Publishing

Access to resources Recommend Favorite

Novel SLC22A16 polymorphisms and influence on doxorubicin pharmacokinetics in Asian breast cancer patients

By Lal Suman   Wong Zee Wan   Jada Srinivasa Rao   Xiang Xiaoqiang   Chen Shu Xiao   Ang Peter Cher Siang   Figg William D   Lee Edmund JD   Chowbay Balram  

Pharmacogenomics, Vol. 8, Iss. 6, 2007-06 ,pp. : 567-575

Future Medicine

Access to resources Recommend Favorite

Tailoring Therapy for Locally Advanced Breast Cancer Using Molecular Profiles: Are We There Yet?

By Fosker Christopher  

Drugs, Vol. 71, Iss. 15, 2011-10 ,pp. : 1947-1955

Adis International

Access to resources Recommend Favorite

Reply to A failure analysis of invasive breast cancer: Most deaths from disease occur in women not regularly screened

By Webb Matthew L.   Kopans Daniel B.   Cady Blake  

Cancer, Vol. 120, Iss. 18, 2014-09 ,pp. : 2937-2938

Blackwell Publishing

Access to resources Recommend Favorite